Coronavirus / COVID

Fundamental aspects of immunity to SARS-CoV-2 remain elusive. Here is an examination of some potential clues to protection.

A collection of expert perspectives on what the virus itself may mean for future crises.

Influenza vaccination during COVID-19 could keep health resources from being overwhelmed and mitigate cardiovascular risks.

Results from a study suggest that the effects of the virus on the brain may be more profound than respiratory symptoms.

New ACTT-2 data shows a marked benefit from the combination regimen versus lone remdesivir.

RECOVERY trial reported hospitalized COVID-19 patients did not see a benefit compared to those patients who received usual care.

ACTT-1 findings for the Gilead antiviral show it improved chance of clinical improvement by 50% in very ill COVID-19 patients.

In consideration of the idea that the pandemic may lead to greater knowledge and adoption of preventive health measures.

The President gave Regeneron’s therapy, REGN-COV2, a ringing endorsement Wednesday night and stated both companies’ therapies should be given for free to the public.

New research based on animal models suggests cocktails of ultrapotent antibodies might help protect patients against SARS-CoV-2.

The new pathogen panel will distinguish between 20 different common and serious respiratory infections, giving clinicians more confidence in flu season diagnoses.

The response to the pandemic had a focus group of young people concerned for not only themselves but others as well.

Numerous candidates are in late-stage assessment. An expert shares what the diverse agents should show before being considered for regulation.

This further emphasizes the higher rate of mortality in COVID-19 compared to influenza.

A pair of investigative monoclonal antibodies from Lilly show promise for mitigating mild to moderate COVID-19 risks of escalation.

The new guidance bucks against the White House's campaign message of an available prophylaxis by the election.

Perspective on the ongoing independent safety reviews for one of the more promising vaccine candidates.

Within NIH is the National Center for Advancing Translational Sciences (NCATS) and they will oversee the grant awards. Christopher Austin, MD, director, NCATS, discusses the specifics of the 2 trials being expanded.

Prone positioning has been found to improve outcomes for mechanically ventilated patients with COVID-19, and a new study suggests the strategy may also benefit conscious patients requiring continuous positive airway pressure.

Fauci also shares suggestions for college campus to mitigate community-based spread while classes continue.

The President's hospital stay continues through a third day, with conflicting messages on his health and an escalation in therapy.

A discussion with an expert on the particularities of the vaccines, which vary in temperature climate requirements and dosages.

A collection of perspectives on how the virus is affecting patients outside of infectious disease.

Why the AstraZeneca & Oxford University trial's pause due to an adverse event was a sign to Fauci the vaccine monitoring systems are working.

New CDC data showed adults aged 20-29 made up more than 20% of all confirmed cases from June-August of this year.